Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Pregabalin Prevent the Development of Neuropathic Pain Following Spinal Cord Injury? A Double-Blind, Randomized, Placebo Controlled Trial.

NCT00879021 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT00879021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00879021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Pregabalin Prevent the Development of Neuropathic Pain Following Spinal Cord Injury? A Double-Blind, Randomized, Placebo Controlled Trial.
Lead sponsor
Nova Scotia Health Authority
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2009
Completion date
June 30, 2012
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, spinal cord trauma